These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Melanocyte-stimulating hormone and persistent tardive dyskinesia: a hypothesis. Sandyk R Int J Neurosci; 1990 Mar; 51(1-2):45-52. PubMed ID: 1979965 [TBL] [Abstract][Full Text] [Related]
4. Topographic subtypes of tardive dyskinesia: relationship to seborrhea. Sandyk R; Pardeshi R Int J Neurosci; 1990 Oct; 54(3-4):321-3. PubMed ID: 1979973 [No Abstract] [Full Text] [Related]
5. Alpha-melanocyte-stimulating hormone: possible role in the pathophysiology of acute drug-induced dystonia. Sandyk R Int J Neurosci; 1990 Aug; 53(2-4):241-2. PubMed ID: 2176181 [No Abstract] [Full Text] [Related]
6. Role of androgens in tardive dyskinesia. Sandyk R; Kay SR Int J Neurosci; 1991; 56(1-4):215-8. PubMed ID: 1682283 [No Abstract] [Full Text] [Related]
7. MSH and MIF-I in animal models of tardive dyskinesia. Davis KL; Kastin AJ; Beilstein BA; Vento AL Pharmacol Biochem Behav; 1980 Jul; 13(1):37-40. PubMed ID: 6105677 [TBL] [Abstract][Full Text] [Related]
15. Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation. Schultz SK; Miller DD; Arndt S; Ziebell S; Gupta S; Andreasen NC Biol Psychiatry; 1995 Dec; 38(11):713-9. PubMed ID: 8580223 [TBL] [Abstract][Full Text] [Related]
16. Tardive dyskinesia in bipolar disorders: possible role of pineal melatonin. Sandyk R Int J Neurosci; 1990 Jun; 52(3-4):233-8. PubMed ID: 2269610 [TBL] [Abstract][Full Text] [Related]